| FDA approves peginesatide to treat anemia in adult dialysis patients. |
|
| FDA: The U.S. Food and Drug Administration today approved Omontys (peginesatide) to treat anemia, a condition in which the body does not have enough healthy red blood cells, in adult dialysis patients who have chronic kidney disease (CKD). |